Protalix is a publicly traded biotechnology company (NYSE Amex: PLX), that is producing recombinant therapeutic proteins through the ProCellEx™ plant cell system.



PRESS ROOM


PROTALIX BIOTHERAPEUTICS

2 Snunit St., Science Park,
POB 455, Carmiel 20100, Israel.

T:   +972-4-9028100
F:   +972-4-988-9489
E:   
      
© 2007 Protalix Biotherapeutics. All Rights Reserved.